China's Sinopharm says vaccine 79% effective vs coronavirus
Dec 30, 2020 1:42 PM PHT
Phase 3 trials of a Sinopharm coronavirus vaccine found it was 79% effective, the Chinese pharma giant said Wednesday, December 30, lower than rival jabs developed by Pfizer-BioNTech and Moderna but a potential breakthrough in the battle to stem the pandemic in Asia.
China has been racing against the West to develop its own COVID-19 vaccines, with five already in large-scale Phase 3 clinical trials.
But Wednesday's announcement was the first data released regarding the efficacy of a Chinese vaccine candidate.
"The protective effect of the (Sinopharm CNBG Beijing) vaccine against COVID-19 is 79.34%," said the Beijing Institute of Biological Products, a Sinopharm subsidiary.
Sinopharm has applied to China's drug regulator for approval of the inactivated coronavirus vaccine, the statement said, a type of inoculation using particles of the pathogen.
It has also been slow to complete Phase 3 trials, which had to be conducted abroad due to China's success at curbing the spread of COVID-19 within its own borders.
Chinese officials have repeatedly assured the public of the vaccines' safety, claiming that there have been no serious adverse reactions.
More than a million people have already been vaccinated with unapproved vaccines in China under its emergency use program, including frontline health workers, state-owned enterprise employees, and workers planning to travel abroad.
The United Arab Emirates approved a Sinopharm vaccine earlier this month, becoming the first foreign country to approve a China-developed COVID-19 vaccine. It said the vaccine was 86% effective, according to interim results of a Phase 3 trial.
Beijing has pledged to share the vaccine at a fair cost – a potential boost for poorer Asian countries who are otherwise reliant on limited distribution offered by the COVAX scheme.
"China has made the firm commitment that after China's new coronavirus vaccines are completed and put into use, they will serve as a global public product and be supplied to the world at a fair and reasonable price," foreign ministry spokesman Zhao Lijian said Friday.
"We will also give priority to developing countries for vaccines. This will be made through a variety of ways, including through donations and aid," Lijian added. – Rappler.com
bamboo oh bamboo. One and the only one bamboo ctr available full or potential. siapa takda bamboo ctr sini juga mau beli kanger. 2021 bamboo year. kanger is the bamboo ctr of the year. correct?
orang black n white kertas ada action. kanger black n white kertas tulis tapi action yilek. apasal ini macam bcos sinovac is approved vaksin by mosti right. sinopharm pun not in the list of pre order. apa macam kanger mau dapat order. banyak tipis chance lah. betul?
Ularsawa,pergi tengok cermin u punya muka ,tengok u punya fgv sudah jadi apa,u punya mulut busuk lah.u pergi mana counters pun kasi orlang hantam u kaw kaw punya.U mau pangsai pergi lian tempat ,masuk lupang ok, correct,wakak
I Promote bamboo di sini. mana ada kacau di sini. kasi nasihat jangan mimpi sangat vaksin sinopharm. apa salahnya . kan kanger takda vaksin pun sampai hari ini. Siapa yang salah. vaksin promoter macam lbo ex promoter tu kan. bukan I promote vaksin di sini. siapa yang kacau I promote bamboo. dia tu lah anti kanger. Betul?
Yang solution promoter datang sini buat apa. nak pukul ular kahm Ular kasi nasihat di solution bulan lepas mana tak benar. solution not worth rm1.80 sampai hari ini pun benar. Betul?
frankly speaking. not much meat if vaccines supply by gorment foc. private left peanut only. how many willing to pay if gorment give free. not all will accept the vaccine scare side effect may delay it also. Even pharmaniaga get the sinovac refilling. we dunno what is term and condition. All cakap confidential. you know how much they earn per dose kah. no one know also until they supply it and only can see in their next QR after they supply in March. all also speculating very lucrative business. really so kah. no one know also. whether good margin or not nobody know lah. I also dunno. Anyway gorment supply foc cannot be too high cost also lah. Gorment kena accused by opposition said over paid for the vaccine. not scare kena investigate kah if change gorment later. kanger I dont have much hope it will get the vaccine also as 5 vaccines were selected plus another one on 3rd phase trial meaning 3 chinese brands are available in Msia already. Why sinopharm want to fight for the small market like Msia lah. kanger vaccine is more or less dead lah. Yong Tai I dunno lah. I didnt read their story. sorry no comment. Betul?
If kanger does have Sinopharm allocation, there will be demand. Simply because Sinovac just got screwed by Brazil and Sinopharm is the Main vaccine used on China 1.3b population.
Sinovac was offered to china public around november at cost 200 per shot. Not alot of takers I heard. In December, the govt made a u-turn and offered Sinopharm for free to 1.3b people. To date, 6million+ have taken.
The china vaccine theme play is happening so fast because a china vvip is touring asia now before another clown becomes the president. Kickstarted at Myanmar with free sinovac, now at indonesia to witness sinovac rollout. Go check out his itinerary and you will see why suddenly malaysia scrambled to get sinovac approved. Next up are all countries that are preparing to roll out sinovac.
1bil dose not enuf to supply china in 1 year. sinopharm need 2 doses. only 500 chinaman ppl can get vaccine. need 3 yrs like this. Mana possible. China got 5 vaccines under 3rd phase lah. not all will get sinopharm later lah. Only sinopharm approved now doesnt mean others wont get approved later right. even pfizer also china using lah. Correct?
mau marah pun marah those cakap kanger vaksin takda bamboo takda only ada toilet paper lori balak joker and antivac noob dan lain lain cakap kanger is con ctr. I mana ada cakap begini. I promote bamboo kira promoter juga only antivac je. correct?
apa lah. mata ada rabun macam ular kah. Baca pun takda betul betul siapa you nak marah lah. buka ular lah. those anti kanger one mau beli 10sen punya lah. betul?
kalau nak jadi promoter. promote facts lah. jangan tipu orang takda vaksin cakap ada vaksin. mana vaksin. takda pun nampak ada paper tulis kanger punya vaksin sudah approved by npra. Betul?
shoot. no report cakap vaksin will need retake yearly. as the vaksin still new. no one know yet exactly need yearly jab or not. wait for the vaksin company report after a period of time whether the antibody developed still need another jab later. so dont speculate it must be yearly jab like flu vaksin. Even flu vaksin we also never take any jab. so you kena flu virus kah. not right? Correct?
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
apaimiggol
18 posts
Posted by apaimiggol > 2021-01-12 16:45 | Report Abuse
China's Sinopharm says vaccine 79% effective vs coronavirus
Dec 30, 2020 1:42 PM PHT
Phase 3 trials of a Sinopharm coronavirus vaccine found it was 79% effective, the Chinese pharma giant said Wednesday, December 30, lower than rival jabs developed by Pfizer-BioNTech and Moderna but a potential breakthrough in the battle to stem the pandemic in Asia.
China has been racing against the West to develop its own COVID-19 vaccines, with five already in large-scale Phase 3 clinical trials.
But Wednesday's announcement was the first data released regarding the efficacy of a Chinese vaccine candidate.
"The protective effect of the (Sinopharm CNBG Beijing) vaccine against COVID-19 is 79.34%," said the Beijing Institute of Biological Products, a Sinopharm subsidiary.
Sinopharm has applied to China's drug regulator for approval of the inactivated coronavirus vaccine, the statement said, a type of inoculation using particles of the pathogen.
It has also been slow to complete Phase 3 trials, which had to be conducted abroad due to China's success at curbing the spread of COVID-19 within its own borders.
Chinese officials have repeatedly assured the public of the vaccines' safety, claiming that there have been no serious adverse reactions.
More than a million people have already been vaccinated with unapproved vaccines in China under its emergency use program, including frontline health workers, state-owned enterprise employees, and workers planning to travel abroad.
The United Arab Emirates approved a Sinopharm vaccine earlier this month, becoming the first foreign country to approve a China-developed COVID-19 vaccine. It said the vaccine was 86% effective, according to interim results of a Phase 3 trial.
Beijing has pledged to share the vaccine at a fair cost – a potential boost for poorer Asian countries who are otherwise reliant on limited distribution offered by the COVAX scheme.
"China has made the firm commitment that after China's new coronavirus vaccines are completed and put into use, they will serve as a global public product and be supplied to the world at a fair and reasonable price," foreign ministry spokesman Zhao Lijian said Friday.
"We will also give priority to developing countries for vaccines. This will be made through a variety of ways, including through donations and aid," Lijian added. – Rappler.com